Prosecution Insights
Last updated: November 20, 2026

Jake Minh Vu, USPTO Patent Examiner

Listed by the USPTO as VU, JAKE MINH

Tech Center 1600 • Art Units: 1614 1618

This examiner grants 41% of resolved cases

Analysis

VU, JAKE MINH is assigned to USPTO technology center 1600 and art unit 1614. His record covers 809 resolved cases, with a 41.2% allowance rate and a 26.7% interview lift. Median time to allowance is 1521 days. Applicants should plan for a demanding and extended prosecution path, with claim strategy and continuation decisions considered early.

Listed companies include Oxford University Innovation Limited, Boston Scientific Corporation, and Koninklijke Philips N.V. Listed firms are Nixon Peabody LLP, THOMAS | HORSTEMEYER, LLP, and WOLF GREENFIELD & SACKS, P.C. Interviews may assist in clarifying technical distinctions, but the allowance figure supports maintaining realistic expectations about eventual claim scope.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

41.2%
Allow Rate
-18.8% vs TC avg
855
Total Applications
+26.7%
Interview Lift
1521
Avg Prosecution Days
Based on 809 resolved cases, 2023–2026

Rejection Statute Breakdown

0.6%
§101 Eligibility
20.8%
§102 Novelty
41.3%
§103 Obviousness
22.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17414414 INDUCING FAVORABLE EFFECTS ON TUMOR MICROENVIRONMENT VIA ADMINISTRATION OF NANOPARTICLE COMPOSITIONS Non-Final OA Cornell University
18917556 BIODEGRADABLE DRUG ELUTING MICROSPHERE FOR THE TREATMENT OF SOLID TUMORS Non-Final OA Boston Scientific Scimed, Inc.
18267136 INSTANTLY GELLING COMPOSITIONS FOR ARTIFICIAL SALIVA AND ULTRASOUND GELS Non-Final OA KONINKLIJKE PHILIPS N.V.
18248191 METHODS AND COMPOSITIONS FOR IMAGING AND TREATING CANCER Final Rejection WASHINGTON UNIVERSITY
18554944 MICROBUBBLE-ASSISTED ULTRASOUND-GUIDED THERAPY Non-Final OA THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
18908883 METHOD TO RELIEVE STRESS IN CAPSULE SHELLS TO REDUCE PROPENSITY TO BREAK Non-Final OA R.P. Scherer Technologies, LLC
17294368 LIQUIDLY INJECTABLE, SELF-STABILIZING BIOPOLYMERS FOR THE DELIVERY OF RADIONUCLIDE Non-Final OA Duke University
18556703 PHOSPHINATE ESTER-CONTAINING DYES HAVING TUNABLE PROPERTIES AND METHODS OF MAKING THE SAME Non-Final OA NUTECH VENTURES
17786403 RED BLOOD CELL-DERIVED VESICLE Final Rejection Imperial College Innovations Limited
16641059 SLIPPERY MICROPROPELLERS PENETRATE THE VITREOUS HUMOR Final Rejection Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Jake Minh Vu's allowance rate?

41.2% of resolved applications examined by Jake Minh Vu were allowed (809 resolved cases), compared with 48.7% across Art Unit 1614 over the last five years.

Does an interview help with examiner Jake Minh Vu?

This examiner's interview lift is +26.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Jake Minh Vu take to allow a patent?

Applications allowed by Jake Minh Vu took 1,521 days on average from filing to allowance.

Which art unit does examiner Jake Minh Vu work in?

Jake Minh Vu examines applications in Art Unit 1614 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month